Clinical heterogeneity of Alzheimer's disease according to the age of onset

被引:1
|
作者
Vilalta-Franch, J. [1 ,2 ]
Lopez-Pousa, S. [1 ,2 ]
Garre-Olmo, J. [1 ]
Turon-Estrada, A. [2 ]
Pericot-Nierga, I. [2 ]
机构
[1] Hosp Santa Caterina, Inst Assistencia Sanitaria, Unidad Invest, Salt, Girona, Spain
[2] Hosp Santa Caterina, Inst Assistencia Sanitaria, Unidad Valorac Mem & Las Demencias, Salt, Girona, Spain
关键词
cognitive impairment; early-onset Alzheimer's disease; functional deterioration; late-onset Alzheimer's disease; psychological and behavioural disorders;
D O I
10.33588/rn.4502.2007101
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction. The age of onset of Alzheimer's disease (AD) has been linked to the degree of clinical heterogeneity. Some studies have suggested that the presenile and senile forms may be different conditions. Aim. To describe the clinical and developmental characteristics of patients with AD according to the age of onset. Patients and methods. A clinical sample of AD patients was evaluated by means of the Cambridge Examination for Mental Disorders of the Elderly protocol together with other tests and clinical scales (Trail Making Test, Neuropsychiatric Inventory, Rapid-Disability Rating Scale-2 and Zarit Burden Interview). Patients were reassessed at 12 months. Results. Of the 492 participants, 419 (85.2%) were cases of late-onset AD and 73 cases (14.8%) had early-onset AD. For this latter group, the time between onset of the first symptoms and diagnosis of the disease was higher (3.85 versus 2.5 years) and there was a higher frequency of family histories of dementia (35.6%) and personal histories of psychiatric disorders (13.7%). This group also presented better scores on the functional evaluation scales and on the neuropsychological tests, as well as more frequent and severe symptoms of depression. At 12 months no clinical differences were recorded between the two groups, except for an increase in the firequency and severity of apathy. Conclusions. From the differences found between early-onset and late-onset AD we cannot consider them to be two different conditions from the clinical and/or neuropsychological point of view.
引用
收藏
页码:67 / 72
页数:6
相关论文
共 50 条
  • [21] Mutations Modifying Sporadic Alzheimer's Disease Age of Onset
    Velez, Jorge I.
    Lopera, Francisco
    Patel, Hardip R.
    Johar, Angad S.
    Cai, Yeping
    Rivera, Dora
    Tobon, Carlos
    Villegas, Andres
    Sepulveda-Falla, Diego
    Lehmann, Shaun G.
    Easteal, Simon
    Mastronardi, Claudio A.
    Arcos-Burgos, Mauricio
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2016, 171 (08) : 1116 - 1130
  • [22] Altered age of onset in Alzheimer's disease with diabetes mellitus
    Shirani, Peyman
    Salamone, Alicia R.
    Strutt, Adriana M.
    Schulz, Paule E.
    [J]. ANNALS OF NEUROLOGY, 2008, 64 : S43 - S43
  • [23] Diffusion Tensor Changes According to Age at Onset and Apolipoprotein E Genotype in Alzheimer Disease
    Kim, Min-Jeong
    Seo, Sang Won
    Kim, Sung Tae
    Lee, Jong-Min
    Na, Duk L.
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2016, 30 (04): : 297 - 304
  • [24] Disease Course Varies According to Age and Symptom Length in Alzheimer's Disease
    Barnes, Josephine
    Bartlett, Jonathan W.
    Wolk, David A.
    van der Flier, Wiesje M.
    Frost, Chris
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2018, 64 (02) : 631 - 642
  • [25] Education, occupation and retirement age effects on the age of onset of Alzheimer's disease
    Lupton, Michelle K.
    Stahl, Daniel
    Archer, Nicola
    Foy, Catherine
    Poppe, Michaela
    Lovestone, Simon
    Hollingworth, Paul
    Williams, Julie
    Owen, Micheal J.
    Dowzell, Kimberley
    Abraham, Richard
    Sims, Rebecca
    Brayne, Carol
    Rubinsztein, David
    Gill, Michael
    Lawlor, Brian
    Lynch, Aoibhinn
    Powell, John F.
    [J]. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2010, 25 (01) : 30 - 36
  • [26] Relationship of APOE, age at onset, amyloid and clinical phenotype in Alzheimer disease
    Whitwell, Jennifer L.
    Tosakulwong, Nirubol
    Weigand, Stephen D.
    Graff-Radford, Jonathan
    Ertekin-Taner, Nilufer
    Machulda, Mary M.
    Duffy, Joseph R.
    Schwarz, Christopher G.
    Senjem, Matthew L.
    Jack, Clifford R.
    Lowe, Val J.
    Josephs, Keith A.
    [J]. NEUROBIOLOGY OF AGING, 2021, 108 : 90 - 98
  • [27] Alzheimer's disease: the size of the problem, clinical manifestation and heterogeneity
    Forstl, H
    [J]. JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1998, (54): : 1 - 8
  • [28] Metabolic correlates of clinical heterogeneity in questionable Alzheimer's disease
    Salmon, Eric
    Lekeu, Francoise
    Garraux, Gaetan
    Guillaume, Benedicte
    Magis, Delphine
    Luxen, A.
    Moonen, G.
    Collette, F.
    [J]. NEUROBIOLOGY OF AGING, 2008, 29 (12) : 1823 - 1829
  • [29] Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome
    Lam, Benjamin
    Masellis, Mario
    Freedman, Morris
    Stuss, Donald T.
    Black, Sandra E.
    [J]. ALZHEIMERS RESEARCH & THERAPY, 2013, 5 (01):
  • [30] Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome
    Benjamin Lam
    Mario Masellis
    Morris Freedman
    Donald T Stuss
    Sandra E Black
    [J]. Alzheimer's Research & Therapy, 5